VI-60 is a dual, orally active inhibitor of cPLA 2 and COX-2 , which reveals an anti-inflammtory efficacy through the inhibition of p38 MAPK/cPLA 2 /COX-2/PGE 2 pathway.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > COX | Products > Signaling Pathways > Phospholipase
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。